No black box warning on record for Orphenadrine Citrate

As of the latest FDA labeling reviewed, Orphenadrine Citrate (ORPHENADRINE CITRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Orphenadrine Citrate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

No black box warning on record for Orphenadrine Citrate

Other warnings & precautions

WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.

Orphenadrine Citrate Black Box Warning

No black box warning on record for Orphenadrine Citrate

Other warnings & precautions

Orphenadrine Citrate Black Box Warning

No black box warning on record for Orphenadrine Citrate

Other warnings & precautions